103 related articles for article (PubMed ID: 3519615)
1. Reactions of Escherichia coli TEM beta-lactamase with cephalothin and with C10-dipeptidyl cephalosporin esters.
Mobashery S; Johnston M
J Biol Chem; 1986 Jun; 261(17):7879-87. PubMed ID: 3519615
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of alanine racemase by beta-chloro-L-alanine released enzymatically from amino acid and peptide C10-esters of deacetylcephalothin.
Mobashery S; Johnston M
Biochemistry; 1987 Sep; 26(18):5878-84. PubMed ID: 3118951
[TBL] [Abstract][Full Text] [Related]
3. Monitoring beta-lactamase activity in vivo by 13C nuclear magnetic resonance spectroscopy.
Mobashery S; Lerner SA; Johnston M
Antimicrob Agents Chemother; 1988 Aug; 32(8):1196-203. PubMed ID: 3056254
[TBL] [Abstract][Full Text] [Related]
4. 7-(D,L-alpha-fluoro-2-thienylacetamido)cephalosporanic acid (L 14655), a new semisynthetic cephalosporin. Synthesis and preliminary biological evaluation.
Malabarba A; Somma S; Berti M; Cavalleri B
Farmaco Sci; 1984 Dec; 39(12):1050-60. PubMed ID: 6335695
[TBL] [Abstract][Full Text] [Related]
5. Chloroalanyl antibiotic peptides: antagonism of their antimicrobial effects by L-alanine and L-alanyl peptides in gram-negative bacteria.
Cheung KS; Boisvert W; Lerner SA; Johnston M
J Med Chem; 1986 Oct; 29(10):2060-8. PubMed ID: 3093682
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial activity of new C-10 quinolonyl-cephem esters.
Demuth TP; White RE; Tietjen RA; Storrin RJ; Skuster JR; Andersen JA; McOsker CC; Freedman R; Rourke FJ
J Antibiot (Tokyo); 1991 Feb; 44(2):200-9. PubMed ID: 1901312
[TBL] [Abstract][Full Text] [Related]
7. Chromophoric spin-labeled beta-lactam antibiotics for ENDOR structural characterization of reaction intermediates of class A and class C beta-lactamases.
Mustafi D; Hofer JE; Huang W; Palzkill T; Makinen MW
Spectrochim Acta A Mol Biomol Spectrosc; 2004 May; 60(6):1279-89. PubMed ID: 15134725
[TBL] [Abstract][Full Text] [Related]
8. Binding of cephalothin and cefotaxime to D-ala-D-ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases.
Kuzin AP; Liu H; Kelly JA; Knox JR
Biochemistry; 1995 Jul; 34(29):9532-40. PubMed ID: 7626623
[TBL] [Abstract][Full Text] [Related]
9. Novel extended-spectrum TEM-type beta-lactamase from an Escherichia coli isolate resistant to ceftazidime and susceptible to cephalothin.
Chanal-Claris C; Sirot D; Bret L; Chatron P; Labia R; Sirot J
Antimicrob Agents Chemother; 1997 Mar; 41(3):715-6. PubMed ID: 9056022
[TBL] [Abstract][Full Text] [Related]
10. A model system to demonstrate that beta-lactamase-associated antibiotic trapping could be a potential means of resistance.
Gutmann L; Williamson R
J Infect Dis; 1983 Aug; 148(2):316-21. PubMed ID: 6310004
[TBL] [Abstract][Full Text] [Related]
11. Structural aspects for evolution of beta-lactamases from penicillin-binding proteins.
Meroueh SO; Minasov G; Lee W; Shoichet BK; Mobashery S
J Am Chem Soc; 2003 Aug; 125(32):9612-8. PubMed ID: 12904027
[TBL] [Abstract][Full Text] [Related]
12. Site-saturation mutagenesis of Tyr-105 reveals its importance in substrate stabilization and discrimination in TEM-1 beta-lactamase.
Doucet N; De Wals PY; Pelletier JN
J Biol Chem; 2004 Oct; 279(44):46295-303. PubMed ID: 15326193
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymes.
Prinarakis EE; Tzouvelekis LS; Legakis NJ
Chemotherapy; 1998; 44(4):260-4. PubMed ID: 9681202
[TBL] [Abstract][Full Text] [Related]
14. The role of tyrosine 150 in catalysis of beta-lactam hydrolysis by AmpC beta-lactamase from Escherichia coli investigated by site-directed mutagenesis.
Dubus A; Normark S; Kania M; Page MG
Biochemistry; 1994 Jul; 33(28):8577-86. PubMed ID: 8031792
[TBL] [Abstract][Full Text] [Related]
15. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
[TBL] [Abstract][Full Text] [Related]
16. Lytic activity of a new cephalosporin, cefuroxime, against gram-negative bacteria.
Russell AD; Tottle PC
Chemotherapy; 1978; 24(6):354-9. PubMed ID: 359269
[TBL] [Abstract][Full Text] [Related]
17. Clinical isolates of Escherichia coli producing TRI beta-lactamases: novel TEM-enzymes conferring resistance to beta-lactamase inhibitors.
Vedel G; Belaaouaj A; Gilly L; Labia R; Philippon A; Névot P; Paul G
J Antimicrob Chemother; 1992 Oct; 30(4):449-62. PubMed ID: 1490918
[TBL] [Abstract][Full Text] [Related]
18. Patterns of resistance to beta-lactams and characterization of beta-lactamases in Escherichia coli isolates from children in Tunisia.
Réjiba S; Kechrid A
J Chemother; 2007 Aug; 19(4):382-7. PubMed ID: 17855181
[TBL] [Abstract][Full Text] [Related]
19. Kinetics of turnover of cefotaxime by the Enterobacter cloacae P99 and GCl beta-lactamases: two free enzyme forms of the P99 beta-lactamase detected by a combination of pre- and post-steady state kinetics.
Kumar S; Adediran SA; Nukaga M; Pratt RF
Biochemistry; 2004 Mar; 43(9):2664-72. PubMed ID: 14992604
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of beta-lactamase production of multiple resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
Tsuji H; Ohashi Y; Okumura K; Tsuji A; Muto Y; Goto S
Chemotherapy; 1982; 28(1):26-39. PubMed ID: 7035089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
